SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-16-698460
Filing Date
2016-08-31
Accepted
2016-08-31 17:01:48
Documents
5
Effectiveness Date
2016-08-31

Document Format Files

Seq Description Document Type Size
1 S-8 d249448ds8.htm S-8 54971
2 OPINION OF MAZANTI-ANDERSON KORSO JENSEN d249448dex51.htm EX-5.1 7258
3 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM d249448dex231.htm EX-23.1 2709
4 GRAPHIC g249448g09g15.jpg GRAPHIC 10472
5 GRAPHIC g249448g26i87.jpg GRAPHIC 3739
  Complete submission text file 0001193125-16-698460.txt   85753
Mailing Address TUBORG BOULEVARD 5 HELLERUP G7 DK-2900
Business Address TUBORG BOULEVARD 5 HELLERUP G7 DK-2900 45 36 94 44 86
Ascendis Pharma A/S (Filer) CIK: 0001612042 (see all company filings)

IRS No.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-213412 | Film No.: 161863836
SIC: 2834 Pharmaceutical Preparations